Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? [electronic resource]
Producer: 20050303Description: 26-30 p. digitalISSN:- 0924-8579
- Adolescent
- Amphotericin B -- therapeutic use
- Animals
- Antimony
- Antiprotozoal Agents -- therapeutic use
- Child
- Child, Preschool
- Female
- Greece
- Humans
- Infant
- Infant, Newborn
- Leishmania infantum -- drug effects
- Leishmaniasis, Visceral -- drug therapy
- Liposomes
- Male
- Meglumine -- therapeutic use
- Meglumine Antimoniate
- Organometallic Compounds -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.